Hoey Investments Inc. Sells 2,335 Shares of Astera Labs, Inc. $ALAB

Hoey Investments Inc. trimmed its position in Astera Labs, Inc. (NASDAQ:ALAB) by 31.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,117 shares of the company’s stock after selling 2,335 shares during the quarter. Hoey Investments Inc.’s holdings in Astera Labs were worth $561,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. Eurizon Capital SGR S.p.A. purchased a new stake in Astera Labs during the 4th quarter valued at approximately $18,708,000. Nordea Investment Management AB purchased a new position in shares of Astera Labs in the fourth quarter worth $2,028,000. Swedbank AB lifted its holdings in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares in the last quarter. Numerai GP LLC boosted its position in shares of Astera Labs by 153.1% during the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares during the last quarter. Finally, Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in shares of Astera Labs during the fourth quarter worth $499,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on ALAB shares. Barclays boosted their price target on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Morgan Stanley increased their price target on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Royal Bank Of Canada lifted their price objective on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. Finally, Stifel Nicolaus upped their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $265.75.

Insider Buying and Selling at Astera Labs

In other news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the transaction, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 2,164,441 shares of company stock valued at $526,198,280. 10.40% of the stock is owned by company insiders.

Astera Labs Stock Performance

ALAB opened at $394.45 on Tuesday. The stock’s 50 day moving average price is $314.72 and its 200-day moving average price is $205.99. Astera Labs, Inc. has a one year low of $88.18 and a one year high of $499.48. The stock has a market cap of $67.61 billion, a price-to-earnings ratio of 269.91, a P/E/G ratio of 4.66 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the company earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.